Normal and pathological functions of mammalian retroelements

por Deisseroth, Albert
Publicado 2005

Activation of phenotypic expression of human globin genes from nonerythroid cells by chromosome-dependent transfer to tetraploid mouse erythroleukemia cells

por Deisseroth, Albert, Hendrick, Don
Publicado 1979

FOCiS on Damage Associated Molecular Pattern Molecules

por Lotze, Michael T., Deisseroth, Albert, Rubartelli, Anna
Publicado 2007

Use of Adenoviral Vectors to Target Chemotherapy to Tumor Vascular Endothelial Cells Suppresses Growth of Breast Cancer and Melanoma

por Li, Pingchuan, Liu, Yanzheng, Maynard, Jonathan, Tang, Yucheng, Deisseroth, Albert
Publicado 2010

Alteration of the Cytotoxic Action of Sensitized Lymphocytes by Cholinergic Agents and Activators of Adenylate Cyclase

por Strom, Terry B., Deisseroth, Albert, Morganroth, Joel, Carpenter, Charles B., Merrill, John P.
Publicado 1972

Chromosomal localization of human β globin gene on human chromosome 11 in somatic cell hybrids

por Deisseroth, Albert, Nienhuis, Arthur, Lawrence, Jeanne, Giles, Richard, Turner, Patricia, Ruddle, Frank H.
Publicado 1978

An adenoviral vector cancer vaccine that delivers a tumor-associated antigen/CD40-ligand fusion protein to dendritic cells

por Zhang, Lixin, Tang, Yucheng, Akbulut, Hakan, Zelterman, Daniel, Linton, Phyllis-Jean, Deisseroth, Albert B.
Publicado 2003

Vaccination of Rabbits with an Adenovirus Vector Expressing the Papillomavirus E2 Protein Leads to Clearance of Papillomas and Infection

por Brandsma, Janet L., Shlyankevich, Mark, Zhang, Lixin, Slade, Martin D., Goodwin, Edward C., Peh, Woei, Deisseroth, Albert B.
Publicado 2004

U.S. Food and Drug Administration Benefit‐Risk Assessment of Nilotinib Treatment Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia in a Sustained Molecular Re...

por Pulte, E. Dianne, Wroblewski, Tanya, Bloomquist, Erik, Tang, Shenghui, Farrell, Ann, Deisseroth, Albert, McKee, Amy E., Pazdur, Richard
Publicado en Oncologist (2019)

EBNA1 regulates cellular gene expression by binding cellular promoters

por Canaan, Allon, Haviv, Izhak, Urban, Alexander E., Schulz, Vincent P., Hartman, Steve, Zhang, Zhengdong, Palejev, Dean, Deisseroth, Albert B., Lacy, Jill, Snyder, Michael, Gerstein, Mark, Weissman, Sherman M.
Publicado 2009

FDA Approval Summary: Ruxolitinib for Treatment of Steroid‐Refractory Acute Graft‐Versus‐Host Disease

por Przepiorka, Donna, Luo, Lola, Subramaniam, Sriram, Qiu, Junshan, Gudi, Ramadevi, Cunningham, Lea C., Nie, Lei, Leong, Ruby, Ma, Lian, Sheth, Christopher, Deisseroth, Albert, Goldberg, Kirsten B., Blumenthal, Gideon M., Pazdur, Richard
Publicado en Oncologist (2019)

Differentiation syndrome with ivosidenib and enasidenib treatment in patients with relapsed or refractory IDH-mutated AML: a U.S. Food and Drug Administration systematic analysis

por Norsworthy, Kelly J., Mulkey, Flora, Scott, Emma C., Ward, Ashley F., Przepiorka, Donna, Charlab, Rosane, Dorff, Sarah, Deisseroth, Albert B., Kazandjian, Dickran, Sridhara, Rajeshwari, Beaver, Julia A., Farrell, Ann T., de Claro, R. Angelo, Pazdur, Richard
Publicado en Clin Cancer Res (2020)

Considerations in the development of circulating tumor cell technology for clinical use

por Parkinson, David R, Dracopoli, Nicholas, Petty, Brenda Gumbs, Compton, Carolyn, Cristofanilli, Massimo, Deisseroth, Albert, Hayes, Daniel F, Kapke, Gordon, Kumar, Prasanna, Lee, Jerry SH, Liu, Minetta C, McCormack, Robert, Mikulski, Stanislaw, Nagahara, Larry, Pantel, Klaus, Pearson-White, Sonia, Punnoose, Elizabeth A, Roadcap, Lori T, Schade, Andrew E, Scher, Howard I, Sigman, Caroline C, Kelloff, Gary J
Publicado 2012